Results 111 to 120 of about 532,737 (293)

VASCULAR RESISTANCE IN ESSENTIAL HYPERTENSION: RELATIONSHIP BETWEEN OVERALL PERIPHERAL AND REGIONAL VASCULAR RESISTANCE

open access: yesРоссийский кардиологический журнал, 2001
Vascular resistance in essential hypertension: relationship between overall peripheral and regional vascular resistance.
V. F. Lukyanov   +2 more
doaj  

Perfusable Brain Microvascular Network‐On‐Chip Model to Study Flavivirus NS1‐Induced Endothelial Dysfunction

open access: yesAdvanced Functional Materials, EarlyView.
This study presents a microfluidic brain microvascular network‐on‐chip (BMVasChip) to investigate endothelial barrier dysfunction caused by flavivirus non‐structural protein 1 (NS1), including virus‐ and time‐dependent vascular damage, leakiness, and dysfunction.
Monika Rajput   +5 more
wiley   +1 more source

Pro-inflammatory responses after peptide-based cancer immunotherapy

open access: yesHeliyon
Therapeutic vaccinations are designed to prevent cancer by inducing immune responses against tumor antigens. in cancer cells, tumor-associated antigens (TAA) or tumor-specific (mutated) derived peptides are presented within the clefts of main ...
Hanie Mahaki   +9 more
doaj   +1 more source

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

open access: yesAdvanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang   +9 more
wiley   +1 more source

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation

open access: yesiScience
Summary: Current therapies ultimately fail to eradicate metastatic renal cell carcinoma (RCC). Validated biomarkers and a better understanding of the mechanisms causing therapy resistance are still needed.
Andrea Emanuelli   +13 more
doaj   +1 more source

ANOXIA AND HUMAN PULMONARY VASCULAR RESISTANCE 12

open access: bronze, 1951
Richard N. Westcott   +4 more
openalex   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

open access: yesAdvanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth   +2 more
wiley   +1 more source

Management of systemic to pulmonary shunts and elevated pulmonary vascular resistance. [PDF]

open access: yesERJ Open Res, 2023
Linder AN   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy